Subdermal Contraceptive Implants Market Share, Size, Trends, Industry Analysis Report, By Product; By End-Use; By Regions; Segment Forecast, 2021

The global subdermal contraceptive implants market size is expected to reach USD 973.5 million by 2028 according to this new study. The report “Subdermal Contraceptive Implants Market Share, Size, Trends, Industry Analysis Report, By Product (Levonorgestrel Implant, Etonogestrel Implant, Others); By End-Use (Hospitals, Clinics, Diagnostic Centers, Others); By Regions; Segment Forecast, 2021-2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for subdermal contraceptive implants is expected to increase during the forecast period owing to increasing awareness regarding sexual health, rising cases of unwanted pregnancies, and government regulations regarding population control. Technological advancements, the introduction of affordable implants, and a growing population drive the market growth.

The market demand for etonogestrel subdermal contraceptive implants was high in 2020. Etonogestrel implants are the long-term contraceptive solution, implanted under the skin of the upper arm. The increasing population, growing initiatives for population control, rising concerns regarding sexual health, and increasing healthcare expenditure in developing countries, such as India, China, and Japan, boost the adoption of subdermal contraceptive implants.

Subdermal contraceptive implants are used in diagnostic centers, hospitals, clinics, and others. The hospital segment accounted for the highest share in 2020. Availability of advanced healthcare infrastructure and the growing need to offer high-quality healthcare services drives the growth of this segment. Governments across the globe are introducing programs and awareness campaigns for population control through collaboration with hospitals, resulting in increased adoption of these implants.

North America dominated the global market for subdermal contraceptive implants in 2020 and is expected to maintain its dominance over the forecast period. High disposable income, the presence of leading market players, and technological advancements support the market growth in this region. Supportive government regulations and the presence of well-established healthcare infrastructure further increases the demand for subdermal contraceptive implants in North America.

Asia Pacific market for subdermal contraceptive implants is expected to experience significant growth during the forecast period owing to increasing health awareness, rising spending on healthcare, and significant government schemes. Leading global market players are expanding their presence in developing nations of China, Japan, India, and South Korea to tap the growth opportunities offered by these countries.

On account of the technological advancements, and greater need to cater to customer requirements, companies are collaborating in order to strengthen the market presence and gain subdermal contraceptive implants industry share. Broadening of the product portfolio is another trend that is visible in the industry.

Some of the major market participants in subdermal contraceptive implants industry include Karex Industries, Bayer AG, Teva Pharmaceutical Industries Ltd., KESSEL medintim GmbH, Allergan plc, Shanghai Dahua Pharmaceutical Co., Ltd., The Female Health Company, Reckitt Benckiser Group plc, Merck & Co., Inc, and Mayer Laboratories.

The publisher has segmented the subdermal contraceptive implants market report on the basis of product, end-use, and region:

Subdermal Contraceptive Implants Product Outlook (Revenue, USD Million, 2016-2028)

Levonorgestrel Implant
Etonogestrel Implant
Others

Subdermal Contraceptive Implants End-User Outlook (Revenue, USD Million, 2016-2028)

Hospitals
Clinics
Diagnostic Centers
Others

Subdermal Contraceptive Implants Regional Outlook (Revenue, USD Million, 2016-2028)

North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
RoE
Asia Pacific
China
India
Japan
South Korea
RoAPAC
Latin America
Brazil
Mexico
Colombia
RoLATAM
Middle East & Africa
Saudi Arabia
South Africa
Israel
UAE
RoMEA

Frequently Asked Questions about the Subdermal Contraceptive Implants Market

What is the estimated value of the Subdermal Contraceptive Implants Market?

The Subdermal Contraceptive Implants Market was estimated to be valued at $757.2 Million in 2021.

What is the growth rate of the Subdermal Contraceptive Implants Market?

The growth rate of the Subdermal Contraceptive Implants Market is 3.4%, with an estimated value of $973.5 Million by 2028.

What is the forecasted size of the Subdermal Contraceptive Implants Market?

The Subdermal Contraceptive Implants Market is estimated to be worth $973.5 Million by 2028.

Who are the key companies in the Subdermal Contraceptive Implants Market?

Key companies in the Subdermal Contraceptive Implants Market include Karex Industries, Bayer AG, Teva Pharmaceutical Industries Ltd., KESSEL medintim GmbH, Allergan plc, Shanghai Dahua Pharmaceutical Co. Ltd., The Female Health Company, Reckitt Benckiser Group plc and Mayer Laboratories..

Report Attribute	Details
No. of Pages	105
Published	April 2021
Forecast Period	2021 - 2028
Estimated Market Value ( USD ) in 2021	$ 757.2 Million
Forecasted Market Value ( USD ) by 2028	$ 973.5 Million
Compound Annual Growth Rate	3.4%
Regions Covered	Global
No. of Companies Mentioned	10

1. Chapter 1. Introduction

1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Chapter 2. Executive Summary

2.1. Market Highlights

3. Chapter 3. Research Methodology

3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Chapter 4. Subdermal Contraceptive Implants Market Insights

4.1. Subdermal Contraceptive Implants - Industry snapshot
4.2. Subdermal Contraceptive Implants Market Dynamics
4.2.1. Drivers and Opportunities
4.2.2. Restraints and Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Threats of New Entrants
4.3.3. Bargaining Power of Buyers
4.3.4. Threats of Substitute
4.3.5. Rivalry among existing firms
4.4. Subdermal Contraceptive Implants Market PESTLE Analysis
4.5. Value Chain Analysis
4.6. Competitive Ranking Analysis, 2020
4.7. COVID-19 Impact Analysis

5. Chapter 5. Subdermal Contraceptive Implants Market Assessment by Product

5.1. Introduction
5.1.1. Global Subdermal Contraceptive Implants Market Share, By Product, 2020 & 2028
5.2. Levonorgestrel Implant
5.2.1. Global Subdermal Contraceptive Implants Market, by Levonorgestrel Implant, 2016-2028 (USD Million)
5.2.2. Global Subdermal Contraceptive Implants Market, by Levonorgestrel Implant, by Region, 2016-2028 (USD Million)
5.3. Etonogestrel Implant
5.3.1. Global Subdermal Contraceptive Implants Market, by Etonogestrel Implant, 2016-2028 (USD Million)
5.3.2. Global Subdermal Contraceptive Implants Market, by Etonogestrel Implant, by Region, 2016-2028 (USD Million)
5.4. Others
5.4.1. Global Subdermal Contraceptive Implants Market, by Others, 2016-2028 (USD Million)
5.4.2. Global Subdermal Contraceptive Implants Market, by Others, by Region, 2016-2028 (USD Million)

6. Chapter 6. Subdermal Contraceptive Implants Market Assessment by End-User

6.1. Introduction
6.1.1. Global Subdermal Contraceptive Implants Market Share, By End-User, 2020 & 2028
6.2. Hospitals
6.2.1. Global Subdermal Contraceptive Implants Market, by Hospitals, 2016-2028 (USD Million)
6.2.2. Global Subdermal Contraceptive Implants Market, by Hospitals, by Region, 2016-2028 (USD Million)
6.3. Clinics
6.3.1. Global Subdermal Contraceptive Implants Market, by Clinics, 2016-2028 (USD Million)
6.3.2. Global Subdermal Contraceptive Implants Market, by Clinics, by Region, 2016-2028 (USD Million)
6.4. Diagnostic Centers
6.4.1. Global Subdermal Contraceptive Implants Market, by Diagnostic Centers, 2016-2028 (USD Million)
6.4.2. Global Subdermal Contraceptive Implants Market, by Diagnostic Centers, by Region, 2016-2028 (USD Million)
6.5. Others
6.5.1. Global Subdermal Contraceptive Implants Market, by Others, 2016-2028 (USD Million)
6.5.2. Global Subdermal Contraceptive Implants Market, by Others, by Region, 2016-2028 (USD Million)

7. Chapter 7. Subdermal Contraceptive Implants Market Assessment by Geography

7.1. Introduction
7.1.1. Global Subdermal Contraceptive Implants Market Share, By Geography, 2020 & 2028
7.2. Subdermal Contraceptive Implants Market - North America
7.2.1. North America: Subdermal Contraceptive Implants Market, by Country, 2016-2028 (USD Million)
7.2.2. North America: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.2.3. North America: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.2.4. Subdermal Contraceptive Implants Market - U. S.
7.2.4.1. U. S.: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.2.4.2. U. S.: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.2.5. Subdermal Contraceptive Implants Market - Canada
7.2.5.1. Canada: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.2.5.2. Canada: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.3. Subdermal Contraceptive Implants Market - Europe
7.3.1. Europe: Subdermal Contraceptive Implants Market, by Country, 2016-2028 (USD Million)
7.3.2. Europe: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.3.3. Europe: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.3.4. Subdermal Contraceptive Implants Market - Germany
7.3.4.1. Germany: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.3.4.2. Germany: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.3.5. Subdermal Contraceptive Implants Market - UK
7.3.5.1. UK: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.3.5.2. UK: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.3.6. Subdermal Contraceptive Implants Market - France
7.3.6.1. France: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.3.6.2. France: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.3.7. Subdermal Contraceptive Implants Market - Italy
7.3.7.1. Italy: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.3.7.2. Italy: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.3.8. Subdermal Contraceptive Implants Market - Spain
7.3.8.1. Spain: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.3.8.2. Spain: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.3.9. Subdermal Contraceptive Implants Market - Rest of Europe
7.3.9.1. Rest of Europe: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.3.9.2. Rest of Europe: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.4. Subdermal Contraceptive Implants Market - Asia-Pacific
7.4.1. Asia-Pacific: Subdermal Contraceptive Implants Market, by Country, 2016-2028 (USD Million)
7.4.2. Asia-Pacific: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.4.3. Asia-Pacific: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.4.4. Subdermal Contraceptive Implants Market - China
7.4.4.1. China: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.4.4.2. China: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.4.5. Subdermal Contraceptive Implants Market - India
7.4.5.1. India: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.4.5.2. India: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.4.6. Subdermal Contraceptive Implants Market - Japan
7.4.6.1. Japan: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.4.6.2. Japan: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.4.7. Subdermal Contraceptive Implants Market - South Korea
7.4.7.1. South Korea: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.4.7.2. South Korea: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.4.8. Subdermal Contraceptive Implants Market - Rest of APAC
7.4.8.1. Rest of APAC: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.4.8.2. Rest of APAC: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.5. Subdermal Contraceptive Implants Market - Latin America
7.5.1. Latin America: Subdermal Contraceptive Implants Market, by Country, 2016-2028 (USD Million)
7.5.2. Latin America: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.5.3. Latin America: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.5.4. Subdermal Contraceptive Implants Market - Brazil
7.5.4.1. Brazil: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.5.4.2. Brazil: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.5.5. Subdermal Contraceptive Implants Market - Mexico
7.5.5.1. Mexico: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.5.5.2. Mexico: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.5.6. Subdermal Contraceptive Implants Market - Columbia
7.5.6.1. Columbia: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.5.6.2. Columbia: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.5.7. Subdermal Contraceptive Implants Market - Rest of Latin America
7.5.7.1. Rest of Latin America: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.5.7.2. Rest of Latin America: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.6. Subdermal Contraceptive Implants Market - Middle East and Africa
7.6.1. Middle East & Africa: Subdermal Contraceptive Implants Market, by Country, 2016-2028 (USD Million)
7.6.2. Middle East & Africa: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.6.3. Middle East & Africa: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.6.4. Subdermal Contraceptive Implants Market - Saudi Arabia
7.6.4.1. Saudi Arabia: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.6.4.2. Saudi Arabia: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.6.5. Subdermal Contraceptive Implants Market - South Africa
7.6.5.1. South Africa: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.6.5.2. South Africa: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.6.6. Subdermal Contraceptive Implants Market - Israel
7.6.6.1. Israel: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.6.6.2. Israel: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.6.7. Subdermal Contraceptive Implants Market - UAE
7.6.7.1. UAE: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.6.7.2. UAE: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
7.6.8. Subdermal Contraceptive Implants Market - Rest of MEA
7.6.8.1. Rest of MEA: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
7.6.8.2. Rest of MEA: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)

8. Chapter 8. Competitive Landscape

8.1. Expansion and Product Launch Analysis
8.1.1. Expansion
8.1.2. Product Launch
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Chapter 9. Company Profiles

9.1. Karex Industries
9.1.1. Business Overview
9.1.2. Financial Snapshot
9.1.3. Products and Services Benchmarking
9.1.4. Recent Developments
9.2. Bayer AG
9.2.1. Business Overview
9.2.2. Financial Snapshot
9.2.3. Products and Services Benchmarking
9.2.4. Recent Developments
9.3. Teva Pharmaceutical Industries Ltd.
9.3.1. Business Overview
9.3.2. Financial Snapshot
9.3.3. Products and Services Benchmarking
9.3.4. Recent Developments
9.4. KESSEL medintim GmbH
9.4.1. Business Overview
9.4.2. Financial Snapshot
9.4.3. Products and Services Benchmarking
9.4.4. Recent Developments
9.5. Allergan plc
9.5.1. Business Overview
9.5.2. Financial Snapshot
9.5.3. Products and Services Benchmarking
9.5.4. Recent Developments
9.6. Shanghai Dahua Pharmaceutical Co., Ltd.
9.6.1. Business Overview
9.6.2. Financial Snapshot
9.6.3. Products and Services Benchmarking
9.6.4. Recent Developments
9.7. The Female Health Company
9.7.1. Business Overview
9.7.2. Financial Snapshot
9.7.3. Products and Services Benchmarking
9.7.4. Recent Developments
9.8. Reckitt Benckiser Group plc
9.8.1. Business Overview
9.8.2. Financial Snapshot
9.8.3. Products and Services Benchmarking
9.8.4. Recent Developments
9.9. Merck & Co., Inc.
9.9.1. Business Overview
9.9.2. Financial Snapshot
9.9.3. Products and Services Benchmarking
9.9.4. Recent Developments
9.10. Mayer Laboratories
9.10.1. Business Overview
9.10.2. Financial Snapshot
9.10.3. Products and Services Benchmarking
9.10.4. Recent Developments

List of Tables

Table 1. Drivers and Inhibitors for Global Market
Table 2. Restraints Global Market
Table 3. Global Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 4. Global Subdermal Contraceptive Implants Market, by Levonorgestrel Implant, by Region, 2016-2028 (USD Million)
Table 5. Global Subdermal Contraceptive Implants Market, by Etonogestrel Implant, by Region, 2016-2028 (USD Million)
Table 6. Global Subdermal Contraceptive Implants Market, by Others, by Region, 2016-2028 (USD Million)
Table 7. Global Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 8. Global Subdermal Contraceptive Implants Market, by Hospitals, by Region, 2016-2028 (USD Million)
Table 9. Global Subdermal Contraceptive Implants Market, by Clinics, by Region, 2016-2028 (USD Million)
Table 10. Global Subdermal Contraceptive Implants Market, by Diagnostic Centers, by Region, 2016-2028 (USD Million)
Table 11. Global Subdermal Contraceptive Implants Market, by Others, by Region, 2016-2028 (USD Million)
Table 12. Global Subdermal Contraceptive Implants Market, By Geography, 2016 - 2028 (USD Million)
Table 13. North America: Subdermal Contraceptive Implants Market, by Country, 2016-2028 (USD Million)
Table 14. North America: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 15. North America: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 16. U.S.: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 17. U.S.: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 18. Canada: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 19. Canada: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 20. Europe: Subdermal Contraceptive Implants Market, by Country, 2016-2028 (USD Million)
Table 21. Europe: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 22. Europe: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 23. Germany: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 24. Germany: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 25. UK: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 26. UK: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 27. France: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 28. France: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 29. Italy: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 30. Italy: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 31. Spain: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 32. Spain: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 33. Rest of Europe: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 34. Rest of Europe: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 35. Asia-Pacific: Subdermal Contraceptive Implants Market, by Country, 2016-2028 (USD Million)
Table 36. Asia-Pacific: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 37. Asia-Pacific: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 38. China: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 39. China: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 40. India: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 41. India: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 42. Japan: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 43. Japan: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 44. South Korea: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 45. South Korea: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 46. Rest of Asia Pacific: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 47. Rest of Asia Pacific: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 48. Latin America: Subdermal Contraceptive Implants Market, By Country, 2016 - 2028 (USD Million)
Table 49. Latin America: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 50. Latin America: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 51. Brazil: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 52. Brazil: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 53. Mexico: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 54. Mexico: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 55. Columbia: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 56. Columbia: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 57. Rest of Latin America: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 58. Rest of Latin America: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 59. Middle East and Africa: Subdermal Contraceptive Implants Market, By Country, 2016 - 2028 (USD Million)
Table 60. Middle East and Africa: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 61. Middle East and Africa: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 62. Saudi Arabia: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 63. Saudi Arabia: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 64. South Africa: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 65. South Africa: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 66. Israel: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 67. Israel: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 68. UAE: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 69. UAE: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)
Table 70. Rest of Middle East & Africa: Subdermal Contraceptive Implants Market, By Product, 2016 - 2028 (USD Million)
Table 71. Rest of Middle East & Africa: Subdermal Contraceptive Implants Market, By End-User, 2016 - 2028 (USD Million)

List of Figures

Figure 1. Market snapshot
Figure 2. Market segmentation & scope
Figure 3. Global Subdermal Contraceptive Implants market size and growth prospects, 2016 - 2028
Figure 4. Value chain analysis
Figure 5. Subdermal Contraceptive Implants market dynamics
Figure 6. Key market opportunities - prioritized
Figure 7. Industry analysis - Porter’s
Figure 8. PESTEL analysis
Figure 9. Global Subdermal Contraceptive Implants market share by Product, 2020 & 2028
Figure 10. Global Subdermal Contraceptive Implants market share by End-User, 2020 & 2028
Figure 11. Global Subdermal Contraceptive Implants market share by Region, 2020 & 2028
Figure 12. Competitive environment
Figure 13. Strategy framework

Companies Mentioned

Karex Industries
Bayer AG
Teva Pharmaceutical Industries Ltd.
KESSEL medintim GmbH
Allergan plc
Shanghai Dahua Pharmaceutical Co. Ltd.
The Female Health Company
Reckitt Benckiser Group plc
Merck & Co. Inc.
Mayer Laboratories.

Subdermal Contraceptive Implants Market Share, Size, Trends, Industry Analysis Report, By Product; By End-Use; By Regions; Segment Forecast, 2021 - 2028

The publisher has segmented the subdermal contraceptive implants market report on the basis of product, end-use, and region:

Subdermal Contraceptive Implants Product Outlook (Revenue, USD Million, 2016-2028)

Subdermal Contraceptive Implants End-User Outlook (Revenue, USD Million, 2016-2028)

Subdermal Contraceptive Implants Regional Outlook (Revenue, USD Million, 2016-2028)

What is the estimated value of the Subdermal Contraceptive Implants Market?

What is the growth rate of the Subdermal Contraceptive Implants Market?

What is the forecasted size of the Subdermal Contraceptive Implants Market?

Who are the key companies in the Subdermal Contraceptive Implants Market?

Table of Contents

Companies Mentioned

The publisher has segmented the subdermal contraceptive implants market report on the basis of product, end-use, and region:

Subdermal Contraceptive Implants Product Outlook (Revenue, USD Million, 2016-2028)

Subdermal Contraceptive Implants End-User Outlook (Revenue, USD Million, 2016-2028)

Subdermal Contraceptive Implants Regional Outlook (Revenue, USD Million, 2016-2028)

What is the estimated value of the Subdermal Contraceptive Implants Market?

What is the growth rate of the Subdermal Contraceptive Implants Market?

What is the forecasted size of the Subdermal Contraceptive Implants Market?

Who are the key companies in the Subdermal Contraceptive Implants Market?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Subdermal Contraceptive Implants Market Size Outlook to 2028 - Growth Opportunities, Subdermal Contraceptive Implants Market Insights, Companies, Market share by Types, Applications, and Countries

Subdermal Contraceptive Implants Market Growth Opportunities to 2030 - Subdermal Contraceptive Implants Market Size Outlook, Mega Trends, Potential Countries, Types, Applications, Companies, and Developments

Global Subdermal Contraceptive Implants Market (2022-2027) by Type, End-Users, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

Subdermal Contraceptive Implants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Contraceptives Market Analysis by Product (Topical, Oral Contraceptive Pills, Injectable Contraceptives), by Device (Male Condoms, Diaphragms, Female Condoms, Vaginal Rings, Sub Dermal Implants, Intra-Uterine Devices), and by Region - Forecast to 2029